News & Blog
News & Blog
2024 Cure FA Soirée Recap
C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data
Meet the Community – Kyle Duhon
Meet the Community – Hayden Clay Rogers
Meet the Community – Anita Gracey
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
Meet the Community – Tyler Ray Rogers
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
Food and Drug Administration (FDA) removed partial clinical hold following review of Phase 2 dose exploration study data Ongoing open l...
Meet the Community – Bernhard “Bernie” Metz
The Oxford-Harrington Rare Disease Centre Announces Newly Funded Grant Award Programmes to Develop New Therapies for Friedreich’s Ataxia
